VRXA
Veraxa Biotech AG
1.10$
-5.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| – | – | 100.0% | |
| – | – | 34.0% | |
| – | – | 66.0% | |
| – | – | 43,815.1% | |
| – | – | 229,961.1% | |
| – | – | 282,762.7% | |
| – | – | -282,662.7% | |
| – | – | 15.2% | |
| – | – | -286,035.1% | |
| – | – | -284,359.2% | |
| – | – | -277,067.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.